Drug combo shields transplant patients from donor hepatitis c
NCT ID NCT04508907
Summary
This study tests whether a short course of two drugs can prevent hepatitis C from spreading when an organ from an infected donor is transplanted into an uninfected patient. It involves 200 kidney, heart, lung, or pancreas transplant recipients who agree to accept an organ from a hepatitis C-positive donor. The main goal is to see if this treatment stops the recipients from getting the hepatitis C infection.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATITIS C are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mayo Clinic in Arizona
Phoenix, Arizona, 85054, United States
Conditions
Explore the condition pages connected to this study.